Chondrosarcoma, Extraskeletal Myxoid clinical trials

The registry lists 22 studies for Chondrosarcoma, Extraskeletal Myxoid across more than 10 countries. 4 are recruiting or about to start. 1 of them are mainly about Chondrosarcoma, Extraskeletal Myxoid (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-03.

Get an email when these change. Save the Chondrosarcoma, Extraskeletal Myxoid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Terminated: 3
Active, not recruiting: 2
Recruiting: 2
Status unknown: 2
Not yet recruiting: 1

Phase

Phase 2: 14
Phase 1: 8
Phase 3: 4

Where

United States: 15
United Kingdom: 4
Canada: 3
Spain: 3
Puerto Rico: 2
Denmark: 1

Who runs them

National Cancer Institute (NCI) (4) · Salarius Pharmaceuticals, LLC (2) · Grupo Espanol de Investigacion en Sarcomas (2) · City of Hope Medical Center (1) · Children's Oncology Group (1) · Radiation Therapy Oncology Group (1) · Herbert Irving Comprehensive Cancer Center (1) · Sohag University (1)

What is being tested here

Drugs under test in Chondrosarcoma, Extraskeletal Myxoid studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Pazopanib	1	1	4
Seclidemstat	1	0	2
Selinexor	1	0	1
Doxorubicin	0	2	2
Ifosfamide	0	2	2
Nivolumab	0	0	1
Gemcitabine	0	0	1
RG-4733	0	0	1
Romidepsin	0	0	1
Cixutumumab	0	0	1

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Alkylating agents 3

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Jan 2027Radiological Diagnosis of Pediatric Neck Swellings · Sohag University
Jun 2027Proton or Photon RT for Retroperitoneal Sarcomas · Massachusetts General Hospital

Who these studies take

Of the 2 Chondrosarcoma, Extraskeletal Myxoid studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	1 (50%)	1 (50%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	1 (50%)	1 (50%)
50	1 (50%)	1 (50%)
65	1 (50%)	1 (50%)
75	1 (50%)	1 (50%)
85	1 (50%)	1 (50%)

Across all 22 studies, recruiting or not: 14% stop at 75 or younger and 14% at 65; 55% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 22 of 22. search them.